MindWalk Holdings (HYFT) Interest & Investment Income (2020 - 2025)
MindWalk Holdings (HYFT) posted quarterly Interest & Investment Income of $3.6 million for Q3 2025, up 349.14% year-over-year from $810207.6 in Q3 2024, and up 349.14% quarter-over-quarter from -$1.5 million in Q3 2024.
Powered by 
Analysis
MindWalk Holdings (HYFT) Interest & Investment Income (2020 - 2025) Analysis & Trends
MindWalk Holdings (HYFT) has reported Interest & Investment Income for 3 consecutive years, with $3.6 million the latest figure, recorded in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.21 Bn | 132.36 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.73 Bn | 58.55 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 57.59 Bn | 52.46 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 40.13 Bn | 35.04 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.55 Bn | 32.24 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.60 Bn | 27.77 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.70 Bn | 26.54 Bn | 358.27 Mn | 10.98 Mn |
| 10 | MindWalk Holdings | 61.22 Mn | 52.95 Mn | 1.82 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2025 | 3.64 Mn |
| Apr 30, 2025 | -2,108.19 |
| Jan 31, 2025 | 9,157.55 |
| Oct 31, 2024 | 2,196.87 |
| Jul 31, 2024 | -1.46 Mn |
| Apr 30, 2024 | -247,806.81 |
| Jan 31, 2024 | 2,219.16 |
| Oct 31, 2023 | 157,086.20 |
| Jul 31, 2023 | 5.99 Mn |
| Apr 30, 2023 | 36,213.41 |
| Jan 31, 2023 | 28,914.38 |
| Oct 31, 2022 | 27,104.24 |
| Jul 31, 2022 | 3,110.11 |
| Apr 30, 2022 | -219,496.33 |
| Jan 31, 2022 | 126,413.06 |
| Oct 31, 2021 | 409,650.45 |
| Jul 31, 2021 | 3,255.93 |
| Apr 30, 2021 | -195,194.65 |
| Jan 31, 2021 | 9,879.50 |
| Oct 31, 2020 | 390,008.05 |